Operating executive and growth-stage investor with experience in fintech, payments and SaaS who partners with founders to scale revenue, build go-to-market and optimize unit economics. Courtney Haddad brings operating leadership across product, revenue and strategic partnerships, having led cross-functional teams, executed M&A integrations and overseen commercial expansion. Active as an angel and venture investor, strategic advisor and board participant, she is known for data-driven go-to-market playbooks and pragmatic capital allocation.
Operating executive and growth-stage investor with experience in fintech, payments and SaaS who partners with founders to scale revenue, build go-to-market and optimize unit economics. Courtney Haddad brings operating leadership across product, revenue and strategic partnerships, having led cross-functional teams, executed M&A integrations and overseen commercial expansion. Active as an angel and venture investor, strategic advisor and board participant, she is known for data-driven go-to-market playbooks and pragmatic capital allocation.
Combines operator-led investing with a growth-stage focus on fintech, payments and SaaS, prioritizing capital deployment that accelerates revenue scale and improves unit economics. Prefers minority to lead positions where she can partner with founders on go-to-market execution, product-revenue alignment and strategic partnerships. Underwrites opportunities with data-driven GTM metrics, measurable revenue funnels and clear pathways to margin expansion. Time horizon is multi-year growth acceleration with disciplined follow-on allocation and pragmatic risk management.
Combines operator-led investing with a growth-stage focus on fintech, payments and SaaS, prioritizing capital deployment that accelerates revenue scale and improves unit economics. Prefers minority to lead positions where she can partner with founders on go-to-market execution, product-revenue alignment and strategic partnerships. Underwrites opportunities with data-driven GTM metrics, measurable revenue funnels and clear pathways to margin expansion. Time horizon is multi-year growth acceleration with disciplined follow-on allocation and pragmatic risk management.
| Trades 11720 | Longs Won 7921/11720 67% | Profit Factor 9.44 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $1.4M |
| Average Win $292,644.75 | Best Trade (Aug 18) $86.36M | Sharpe Ratio -9.74 |
| Average Loss -$64,659.61 | Worst Trade (Aug 19) -$8.53M | Z-Score 31.17 (100%) |
| Commissions $0 | Avg. Trade Length 1y 1m 1w 6d | Expectancy $176,825.7 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% |
| Consecutive Losing Trades | 166,667 | 150,000 | 133,333 | 116,667 | 100,000 | 83,333 | 66,667 | 50,000 | 33,333 | 16,667 |
| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
A Agilent Technologies Inc. | 2,947 | $368,316.8 | $407,776.39 | - | $39,459.59 | 10.71% | -0.245% |
AAAU Goldman Sachs Physical Gold ETF | 16,560 | $450,215.72 | $661,240.8 | - | $211,025.08 | 46.87% | -1.456% |
AAL American Airlines Group Inc. | 27,222 | $322,216.64 | $415,679.94 | - | $93,463.3 | 29.01% | -1.037% |
AAMI Acadian Asset Management Inc. | 15,386 | $726,459.62 | $1.33M | - | $604,275.52 | 83.18% | +3.026% |
AAOI Applied Optoelectronics, Inc. | 18,623 | $1.58M | $1.76M | - | $181,202.36 | 11.5% | +4.672% |
AAPL Apple Inc. | 1.07M | $237.34M | $329.72M | - | $92.38M | 38.92% | -7.354% |
AB AllianceBernstein Holding L.P. | 16,576 | $564,474.24 | $609,333.76 | - | $44,859.52 | 7.95% | +0.109% |
ABBV AbbVie Inc. | 156,097 | $30.23M | $39.17M | - | $8.94M | 29.58% | -2.513% |
ABCB Ameris Bancorp | 9,013 | $475,898.22 | $786,023.73 | - | $310,125.51 | 65.17% | -0.411% |
ABNB Airbnb, Inc. | 6,578 | $874,781.94 | $996,698.56 | - | $121,916.62 | 13.94% | -0.368% |
ABR Arbor Realty Trust Inc. | 195,358 | $1.83M | $978,743.58 | - | -$855,749 | -46.65% | +4.593% |
ABT Abbott Laboratories | 114,576 | $13.12M | $12.11M | - | -$1.01M | -7.72% | +0.085% |
ABVE Above Food Ingredients Inc. | 15,000 | $23,830 | $1,425 | - | -$22,405 | -94.02% | +11.765% |
ACAD Acadia Pharmaceuticals Inc. | 29,405 | $772,137.25 | $760,707.35 | - | -$11,429.9 | -1.48% | -2.561% |
ACGL Arch Capital Group Ltd | 2,580 | $247,434.44 | $259,367.4 | - | $11,932.96 | 4.82% | -0.603% |
ACHR Archer Aviation Inc. | 66,817 | $457,399.66 | $310,030.88 | - | -$147,368.78 | -32.22% | -2.11% |
ACN Accenture plc Class A | 45,875 | $14.35M | $7.61M | - | -$6.74M | -46.96% | +1.611% |
ACWI iShares MSCI ACWI ETF | 1,683 | $238,172.7 | $263,271.67 | - | $25,098.97 | 10.54% | +0.495% |
ACWV iShares MSCI Global Minimum Volatility ETF | 5,793 | $687,708.85 | $721,112.64 | - | $33,403.79 | 4.86% | -0.328% |
ACWX ISHARES MSCI ACWI EX U.S. ETF | 65,477 | $4.4M | $4.93M | - | $523,272.71 | 11.88% | -0.172% |